News for MYOS Stock

MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020 MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020 MYOS RENS Technology and MedAvail Inc. Announce Merger and Spin-Out of Muscle Health Business